ARCHIVES

Trial In Metastatic Disease To Be Unblinded After Regorafenib Meets Primary Endpoint

This article is from The Cancer Letter archive.

Vol. 34 No. 11 | November 25, 2011

Download PDF Visit The Full Archive

Related Articles

Interim NSABP Leaders Will Not Nominate Chairman, Citing Exec. Committee “Bias”

September 9, 1994

ONS Backs Independent Nursing Research, Splits From ASCO On Meetings

September 3, 1982

NCI’s New Divisional Structure In Place, Next Step Is Review Of Labs, Branches

October 13, 1995

Breast Cancer Working Group Lists Research Needed

July 1, 1988

T-Cell Vaccines Cut Time To Protective Immunity

November 25, 2005

Also AIDS Malignancy Consortium grants to be consolidated on recompetition to one central group chairman’s office.

November 19, 2004